Cargando…

Hi-Plex for high-throughput mutation screening: application to the breast cancer susceptibility gene PALB2

BACKGROUND: Massively parallel sequencing (MPS) has revolutionised biomedical research and offers enormous capacity for clinical application. We previously reported Hi-Plex, a streamlined highly-multiplexed PCR-MPS approach, allowing a given library to be sequenced with both the Ion Torrent and TruS...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nguyen-Dumont, Tú, Teo, Zhi L, Pope, Bernard J, Hammet, Fleur, Mahmoodi, Maryam, Tsimiklis, Helen, Sabbaghian, Nelly, Tischkowitz, Marc, Foulkes, William D, Giles, Graham G, Hopper, John L, Southey, Melissa C, Park, Daniel J
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2013
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3829211/ https://www.ncbi.nlm.nih.gov/pubmed/24206657 http://dx.doi.org/10.1186/1755-8794-6-48

Ejemplares similares

Expanded genetic analysis of a PALB2 c.3113G>A mutation carrying multiple-case breast cancer family via exome sequencing
por: Teo, ZL, et al.
Publicado: (2012)

A PALB2 mutation associated with high risk of breast cancer
por: Southey, Melissa C, et al.
Publicado: (2010)

Targeted massively parallel sequencing characterises the mutation spectrum of PALB2 in breast and ovarian cancer cases from Poland and Ukraine
por: Myszka, Aleksander, et al.
Publicado: (2017)

Is RNASEL:p.Glu265* a modifier of early-onset breast cancer risk for carriers of high-risk mutations?
por: Nguyen-Dumont, Tú, et al.
Publicado: (2018)

Population-Based Estimates of the Age-Specific Cumulative Risk of Breast Cancer for Pathogenic Variants in CHEK2: Findings from the Australian Breast Cancer Family Registry
por: Nguyen-Dumont, Tú, et al.
Publicado: (2021)

Prevalence of PALB2 mutations in Australasian multiple-case breast cancer families
por: Teo, Zhi L, et al.
Publicado: (2013)

Mutation analysis of PALB2 in BRCA1 and BRCA2-negative breast and/or ovarian cancer families from Eastern Ontario, Canada
por: Hartley, Taila, et al.
Publicado: (2014)

Contribution of the PALB2 c.2323C>T [p.Q775X] Founder mutation in well-defined breast and/or ovarian cancer families and unselected ovarian cancer cases of French Canadian descent
por: Tischkowitz, Marc, et al.
Publicado: (2013)

PALB2: research reaching to clinical outcomes for women with breast cancer
por: Southey, Melissa C., et al.
Publicado: (2016)

PALB2 and breast cancer: ready for clinical translation!
por: Southey, Melissa C, et al.
Publicado: (2013)

VTRNA2-1: Genetic Variation, Heritable Methylation and Disease Association
por: Dugué, Pierre-Antoine, et al.
Publicado: (2021)

Identification of a novel truncating PALB2 mutation and analysis of its contribution to early-onset breast cancer in French-Canadian women
por: Foulkes, William D, et al.
Publicado: (2007)

Tumour morphology predicts PALB2 germline mutation status
por: Teo, Z L, et al.
Publicado: (2013)

FANCM and RECQL genetic variants and breast cancer susceptibility: relevance to South Poland and West Ukraine
por: Nguyen-Dumont, Tú, et al.
Publicado: (2018)

ROVER variant caller: read-pair overlap considerate variant-calling software applied to PCR-based massively parallel sequencing datasets
por: Pope, Bernard J, et al.
Publicado: (2014)

Homologous recombination DNA repair defects in PALB2-associated breast cancers
por: Li, Anqi, et al.
Publicado: (2019)

Are the so-called low penetrance breast cancer genes, ATM, BRIP1, PALB2 and CHEK2, high risk for women with strong family histories?
por: Byrnes, Graham B, et al.
Publicado: (2008)

Rare Germline Pathogenic Variants Identified by Multigene Panel Testing and the Risk of Aggressive Prostate Cancer
por: Nguyen-Dumont, Tú, et al.
Publicado: (2021)

Publisher Correction: Homologous recombination DNA repair defects in PALB2-associated breast cancers
por: Li, Anqi, et al.
Publicado: (2019)

Compromised BRCA1-PALB2 interaction is associated with breast cancer risk
por: Foo, Tzeh Keong, et al.
Publicado: (2017)

Identification of new breast cancer predisposition genes via whole exome sequencing
por: Southey, MC, et al.
Publicado: (2012)

Genetic testing in Poland and Ukraine: should comprehensive germline testing of BRCA1 and BRCA2 be recommended for women with breast and ovarian cancer?
por: Nguyen-Dumont, Tu, et al.
Publicado: (2020)

MALDI HiPLEX-IHC: multiomic and multimodal imaging of targeted intact proteins in tissues
por: Lim, Mark J., et al.
Publicado: (2023)

Germ-line DICER1 mutations do not make a major contribution to the etiology of familial testicular germ cell tumours
por: Sabbaghian, Nelly, et al.
Publicado: (2013)

Repeatability of methylation measures using a QIAseq targeted methyl panel and comparison with the Illumina HumanMethylation450 assay
por: Yu, Chenglong, et al.
Publicado: (2021)

To PLEX or Not to PLEX for Amiodarone-Induced Thyrotoxicosis
por: Ahuja, Tania, et al.
Publicado: (2023)

Strategies for Increasing the Depth and Throughput of Protein Analysis by plexDIA
por: Derks, Jason, et al.
Publicado: (2023)

FAVR (Filtering and Annotation of Variants that are Rare): methods to facilitate the analysis of rare germline genetic variants from massively parallel sequencing datasets
por: Pope, Bernard J, et al.
Publicado: (2013)

Population-based estimates of breast cancer risk for carriers of pathogenic variants identified by gene-panel testing
por: Southey, Melissa C., et al.
Publicado: (2021)

The PALB2 p.Leu939Trp mutation is not associated with breast cancer risk
por: Catucci, Irene, et al.
Publicado: (2016)

HiHiMap: single-cell quantitation of histones and histone posttranslational modifications across the cell cycle by high-throughput imaging
por: Zane, Linda, et al.
Publicado: (2017)

Early exploration of two candidate breast cancer susceptibility genes identified by whole-exome sequencing
por: Blanc, R, et al.
Publicado: (2012)

Incorporating Truncating Variants in PALB2, CHEK2 and ATM into the BOADICEA Breast Cancer Risk Model
por: Lee, Andrew J., et al.
Publicado: (2016)

Rapid and High-Throughput Detection of Highly Pathogenic Bacteria by Ibis PLEX-ID Technology
por: Jacob, Daniela, et al.
Publicado: (2012)

NGS-PrimerPlex: High-throughput primer design for multiplex polymerase chain reactions
por: Kechin, Andrey, et al.
Publicado: (2020)

Surgery for BRCA, TP53 and PALB2: a literature review
por: Song, Chin-Vern, et al.
Publicado: (2018)

BioPlexR and BioPlexPy: integrated data products for the analysis of human protein interactions
por: Geistlinger, Ludwig, et al.
Publicado: (2023)

Powering up the mu-PLEX chip
por: Tuuva, T, et al.
Publicado: (1986)

Germline PALB2 Mutations in Cancers and Its Distinction From Somatic PALB2 Mutations in Breast Cancers
por: Hu, Zhe-Yu, et al.
Publicado: (2020)

High-Plex and High-Throughput Digital Spatial Profiling of Non-Small-Cell Lung Cancer (NSCLC)
por: Monkman, James, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_15rpfbjatjbijr93037uml8290